FOREGUT NEUROENDOCRINE TUMOR
Clinical trials for FOREGUT NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new FOREGUT NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for FOREGUT NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat gut tumors: drug blocks cancer growth
Disease control OngoingThis study tests the drug abemaciclib in 20 people with advanced digestive neuroendocrine tumors that have spread, stopped responding to standard treatment, and cannot be removed by surgery. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it …
Matched conditions: FOREGUT NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New drug shows promise in slowing carcinoid tumors
Disease control OngoingThis study tests a drug called pazopanib in 171 people with carcinoid tumors that are getting worse. The goal is to see if pazopanib can slow or stop tumor growth compared to a placebo. Participants take the drug daily and are monitored for how long their disease stays stable.
Matched conditions: FOREGUT NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC